Abbott Laboratories (ABT): Today's Featured Health Services Winner

Abbott Laboratories ( ABT) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day down 0.2%. By the end of trading, Abbott Laboratories rose $0.49 (1.4%) to $35.60 on average volume. Throughout the day, 6,785,613 shares of Abbott Laboratories exchanged hands as compared to its average daily volume of 7,026,400 shares. The stock ranged in a price between $35.14-$35.79 after having opened the day at $35.41 as compared to the previous trading day's close of $35.11. Other companies within the Health Services industry that increased today were: Vision-Sciences Inc (DE ( VSCI), up 9.6%, Cardica ( CRDC), up 8.7%, Dehaier Medical Systems ( DHRM), up 8.5% and IMRIS ( IMRS), up 6.3%.

Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. Abbott Laboratories has a market cap of $54.5 billion and is part of the health care sector. The company has a P/E ratio of 9.1, below the S&P 500 P/E ratio of 17.7. Shares are up 6.8% year to date as of the close of trading on Tuesday. Currently there are 11 analysts that rate Abbott Laboratories a buy, no analysts rate it a sell, and 11 rate it a hold.

TheStreet Ratings rates Abbott Laboratories as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity and reasonable valuation levels. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income, a generally disappointing performance in the stock itself and feeble growth in the company's earnings per share.

On the negative front, Pingtan Marine Enterprise ( PME), down 65.0%, CombiMatrix Corporation ( CBMX), down 14.8%, Stereotaxis ( STXS), down 12.3% and USMD Holdings ( USMD), down 10.1% , were all laggards within the health services industry with CareFusion ( CFN) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

null

More from Markets

FTC Chair Says Agency Is Ready to Take on Big Tech; Walgreens Joins Dow -- ICYMI

FTC Chair Says Agency Is Ready to Take on Big Tech; Walgreens Joins Dow -- ICYMI

Dow Gets Swept Into Nasty Reversal Even as Nasdaq Posts New Record

Dow Gets Swept Into Nasty Reversal Even as Nasdaq Posts New Record

Zoom CEO Eric Yuan Leads Glassdoor's List of Top 100 CEOs

Zoom CEO Eric Yuan Leads Glassdoor's List of Top 100 CEOs

REPLAY: Jim Cramer on Fed Rate Hikes, Oil Prices and Starbucks Worries

REPLAY: Jim Cramer on Fed Rate Hikes, Oil Prices and Starbucks Worries

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists